CN Patent

CN107921023A — 用于治疗偏头痛的包含舒马曲坦的药物组合物

Assigned to Dr Reddys Laboratories Ltd · Expires 2018-04-17 · 8y expired

What this patent protects

本申请涉及治疗人类患者的偏头痛或丛集性头痛的方法，所述方法包括以相当于3mg舒马曲坦基本成分的量皮下施用包含舒马曲坦或其药学上可接受的盐的组合物。

USPTO Abstract

本申请涉及治疗人类患者的偏头痛或丛集性头痛的方法，所述方法包括以相当于3mg舒马曲坦基本成分的量皮下施用包含舒马曲坦或其药学上可接受的盐的组合物。

Drugs covered by this patent

sumatriptan-succinate (SUMATRIPTAN SUCCINATE)

Patent Metadata

Patent number: CN107921023A
Jurisdiction: CN
Classification: —
Expires: 2018-04-17
Drug substance claim: No
Drug product claim: No
Assignee: Dr Reddys Laboratories Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.